NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of Confirmation/Share certificate(s) in lieu of share certificate(s) reported lost/misplaced14-02-2023
14-02-2023
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper Publication Q3 FY23 financial results14-02-2023
NEULAND LABORATORIES LTD. - 524558 - Change Of Name Of Risk Management Committee Of The Company
In line with Neuland's commitment to sustainable development and environmental, social and governance (ESG) priorities, the Company has been taking various initiatives to accelerate its ESG journey. With a view to further strengthen its commitment and enhance Board's oversight on sustainability and ESG matters, the Board of Directors at its meeting held on February 13, 2023 has expanded the scope of the Risk Management Committee and included sustainability and ESG related matters under its purview and renamed the Committee as Risk & Sustainability Committee.13-02-2023
NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022, Along With The Press Release And Investor Presentation.
Unaudited Financial Results for the quarter and nine months ended December 31, 2022, Along With The Press Release And Investor Presentation.13-02-2023
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022, Along With The Press Release And Investor Presentation.
Unaudited Financial Results for the quarter and nine months ended December 31, 2022, Along With The Press Release And Investor Presentation.13-02-2023
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Call Intimation Q3 FY202302-02-2023
NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Details of Loss of Certificate01-02-2023
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 ,inter alia, to consider and approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 202220-01-2023
NEULAND LABORATORIES LTD. - 524558 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201805-01-2023